Search

Your search keyword '"Ness, Kirsten K."' showing total 456 results
Start Over Author "Ness, Kirsten K." Publication Year Range Last 3 years
456 results on '"Ness, Kirsten K."'

5. Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study

Author

de Blank, Peter M. K., Lange, Katharine R., Xing, Mengqi, Mirzaei Salehabadi, Sedigheh, Srivastava, Deokumar, Brinkman, Tara M., Ness, Kirsten K., Oeffinger, Kevin C., Neglia, Joseph, Krull, Kevin R., Nathan, Paul C., Howell, Rebecca, Turcotte, Lucie M., Leisenring, Wendy, Armstrong, Gregory T., Okcu, M. Fatih, and Bowers, Daniel C.

Published
2024
Full Text
View/download PDF

7. Leveraging Clinical Trial Populations and Data from the Children's Oncology Group for Cancer Survivorship Research.

Author

Chow, Eric J, Winestone, Lena E, Lupo, Philip J, Diller, Lisa R, Henderson, Tara O, Kadan-Lottick, Nina S, Levine, Jennifer M, Ness, Kirsten K, Bhatia, Smita, and Armenian, Saro H

Subjects
Health Services and Systems, Biomedical and Clinical Sciences, Health Sciences, Pediatric Cancer, Patient Safety, Pediatric Research Initiative, Clinical Trials and Supportive Activities, Clinical Research, Pediatric, Rare Diseases, Cancer, Prevention, Good Health and Well Being, Adolescent, Cancer Survivors, Child, Delivery of Health Care, Humans, National Cancer Institute (U.S.), Neoplasms, Research, United States, Medical and Health Sciences, Epidemiology, Biomedical and clinical sciences, Health sciences
Abstract

Children and adolescents diagnosed with cancer can now expect an average 85% 5-year overall survival, with significant improvements in longer-term morbidity and mortality reported over the past several decades. However, the long-term impact of therapeutic agents and modalities introduced in recent years remains unclear and will require dedicated follow-up in the years ahead. The Children's Oncology Group (COG), a part of the NCI's National Clinical Trials Network, with over 200 sites across North America and beyond, enrolls more than 10,000 patients onto research protocols annually, inclusive of first-line clinical trials and nontherapeutic studies. COG provides a platform to conduct survivorship research with several unique strengths: (i) a huge catchment to ascertain relatively rare but important adverse events, (ii) study populations that are otherwise too rare to study in smaller consortia, including access to highly diverse patient populations, (iii) long-term follow-up of clinical trial populations linked to the original trial data, and (iv) a natural platform for intervention research. Enhancements in COG infrastructure facilitate survivorship research, including a COG patient registry (Project:EveryChild), availability of a long-term follow-up tracking resource, and successful deployment of various remote-based study procedures to reduce the burden on participants and participating institutions.

Published
2022

8. Design and methods of the StepByStep randomized trial of a mobile health and social media physical activity intervention among adolescent and young adult survivors of childhood cancer: A report from the Children's Oncology Group

Author

Beight, Leah J., Mendoza, Jason A., Leisenring, Wendy M., Collier, Willem, Olsen, Margaret E., Ross, Wilhelmenia L., Santiago-Rivera, Yaiomy, Bryant, Stacy, Rotatori, Jaime, Ness, Kirsten K., Hurtado-de-Mendoza, Alejandra, Baker, K. Scott, Chow, Eric J., and Kadan-Lottick, Nina S.

Published
2024
Full Text
View/download PDF

9. Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors – a genome-wide association study: results from PanCareLIFE

Author

van der Perk, M.E. Madeleine, Broer, Linda, Yasui, Yutaka, Laven, Joop S.E., Robison, Leslie L., Tissing, Wim J.E., Versluys, Birgitta, Bresters, Dorine, Kaspers, Gertjan J.L., Lambalk, Cornelis B., Overbeek, Annelies, Loonen, Jacqueline J., Beerendonk, Catharina C.M., Byrne, Julianne, Berger, Claire, Clemens, Eva, van Dulmen-den Broeder, Eline, Dirksen, Uta, van der Pal, Helena J., de Vries, Andrica C.H., Winther, Jeanette Falck, Ranft, Andreas, Fosså, Sophie D., Grabow, Desiree, Muraca, Monica, Kaiser, Melanie, Kepák, Tomáš, Kruseova, Jarmila, Modan-Moses, Dalit, Spix, Claudia, Zolk, Oliver, Kaatsch, Peter, Kremer, Leontien C.M., Brooke, Russell J., Wang, Fan, Baedke, Jessica L., Uitterlinden, André G., Bos, Annelies M.E., van Leeuwen, Flora E., Ness, Kirsten K., Hudson, Melissa M., van der Kooi, Anne-Lotte L.F., and van den Heuvel-Eibrink, Marry M.

Published
2024
Full Text
View/download PDF

11. The burden of cardiovascular disease and risk for subsequent major adverse cardiovascular events in survivors of childhood cancer: a prospective, longitudinal analysis from the St Jude Lifetime Cohort Study

Author

Hammoud, Rawan A, Liu, Qi, Dixon, Stephanie B, Onerup, Aron, Mulrooney, Daniel A, Huang, I-Chan, Jefferies, John L, Rhea, Isaac B, Ness, Kirsten K, Ehrhardt, Matthew J, Hudson, Melissa M, Ky, Bonnie, Bhakta, Nickhill, Sapkota, Yadav, Yasui, Yutaka, and Armstrong, Gregory T

Published
2024
Full Text
View/download PDF

13. Distinct DNA methylation signatures associated with blood lipids as exposures or outcomes among survivors of childhood cancer: a report from the St. Jude lifetime cohort

Author

Dong, Qian, Chen, Cheng, Song, Nan, Qin, Na, Plonski, Noel-Marie, Finch, Emily R., Shelton, Kyla, Easton, John, Mulder, Heather, Plyer, Emily, Neale, Geoffrey, Walker, Emily, Li, Qian, Huang, I-Chan, Zhang, Jinghui, Wang, Hui, Hudson, Melissa M., Robison, Leslie L., Ness, Kirsten K., and Wang, Zhaoming

Published
2023
Full Text
View/download PDF

18. Physical activity and physical fitness assessments in adolescents and young adults diagnosed with cancer: a scoping review

Author

Caru, Maxime, Wurz, Amanda, Brunet, Jennifer, Barb, Emily D., Adams, Scott C., Roth, Michael E., Winters-Stone, Kerri, Fidler-Benaoudia, Miranda M., Dandekar, Smita, Ness, Kirsten K., Culos-Reed, S. Nicole, Schulte, Fiona, Rao, Pooja, Mizrahi, David, Swartz, Maria Chang, Smith, Marlie, Valle, Carmina G., Kadan-Lottick, Nina S., Dieli-Conwright, Christina M., and Schmitz, Kathryn H.

Published
2023
Full Text
View/download PDF

20. Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study and St Jude Lifetime Cohort

Author

Im, Cindy, Lu, Zhe, Mostoufi-Moab, Sogol, Delaney, Angela, Yu, Lin, Baedke, Jessica L, Han, Yutong, Sapkota, Yadav, Yasui, Yutaka, Chow, Eric J, Howell, Rebecca M, Bhatia, Smita, Hudson, Melissa M, Ness, Kirsten K, Armstrong, Gregory T, Nathan, Paul C, and Yuan, Yan

Published
2023
Full Text
View/download PDF

22. Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study

Author

Chen, Cheng, Qin, Na, Wang, Mingjuan, Dong, Qian, Tithi, Saima Sultana, Hui, Yawei, Chen, Wenan, Wu, Gang, Kennetz, Dennis, Edmonson, Michael N, Rusch, Michael C, Thrasher, Andrew, Easton, John, Mulder, Heather L, Song, Nan, Plonski, Noel-Marie, Shelton, Kyla, Im, Cindy, Ehrhardt, Matthew J, Nichols, Kim E, Leisenring, Wendy M, Stratton, Kayla L, Howell, Rebecca, Yasui, Yutaka, Bhatia, Smita, Armstrong, Gregory T, Ness, Kirsten K, Hudson, Melissa M, Zhang, Jinghui, Wang, Hui, Srivastava, Deo Kumar, Robison, Leslie L, and Wang, Zhaoming

Published
2023
Full Text
View/download PDF

23. Cardiovascular Risk Factor Disparities in Adult Survivors of Childhood Cancer Compared With the General Population

Author

Noyd, David H., Liu, Qi, Yasui, Yutaka, Chow, Eric J., Bhatia, Smita, Nathan, Paul C., Landstrom, Andrew P., Tonorezos, Emily, Casillas, Jacqueline, Berkman, Amy, Ness, Kirsten K., Mulrooney, Daniel A., Leisenring, Wendy M., Howell, Carrie R., Shoag, Jamie, Kirchhoff, Anne, Howell, Rebecca M., Gibson, Todd M., Zullig, Leah L., Armstrong, Gregory T., and Oeffinger, Kevin C.

Published
2023
Full Text
View/download PDF

25. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort

Author

Dixon, Stephanie B, Liu, Qi, Chow, Eric J, Oeffinger, Kevin C, Nathan, Paul C, Howell, Rebecca M, Leisenring, Wendy M, Ehrhardt, Matthew J, Ness, Kirsten K, Krull, Kevin R, Mertens, Ann C, Hudson, Melissa M, Robison, Leslie L, Yasui, Yutaka, and Armstrong, Gregory T

Published
2023
Full Text
View/download PDF

29. Arterial stiffness and aortic hemodynamics as predictors for new or worsening cardiovascular events in childhood cancer survivors: A report from the St. Jude lifetime cohort.

Author

Maharaj, Arun, primary, Dhaduk, Rikeenkumar, additional, Mulrooney, Daniel A., additional, Armstrong, Gregory T., additional, Wogksch, Matthew, additional, Hudson, Melissa M., additional, Ehrhardt, Matthew J., additional, Duprez, Daniel, additional, Dixon, Stephanie B., additional, Krull, Kevin R., additional, and Ness, Kirsten K., additional

Published
2024
Full Text
View/download PDF

34. Using neurocognitive phenotypes to inform interventions for adult survivors of childhood cancer.

Author

Banerjee, Pia, Phillips, Nicholas S, Liu, Wei, Ehrhardt, Matthew J, Bhakta, Nickhill, Brinkman, Tara M, Williams, Annalynn M, Yasui, Yutaka, Khan, Raja B, Srivastava, Deokumar, Ness, Kirsten K, Robison, Leslie L, Hudson, Melissa M, and Krull, Kevin R

Subjects
COGNITIVE processing speed, STROKE, EXECUTIVE function, SMOKING cessation, MEMORY disorders
Abstract

Background Neurocognitive impairments are sequelae of childhood cancer treatment, however little guidance is given to clinicians on common phenotypes of impairment or modifiable risk factors that could lead to personalized interventions in survivorship. Methods Standardized clinical testing of neurocognitive function was conducted in 2958 (74.1%) eligible survivors, who were at least 5 years postdiagnosis and aged older than 18 years, and 477 community controls. Impairment was examined across 20 measures, and phenotypes were determined by latent class analysis. Multinomial logistic regression was used to estimate risk for phenotype, predicted by cancer diagnosis and treatment exposures, chronic health conditions, and lifestyle, adjusted for sex and age. Associations between phenotypes and social attainment were examined. Results Five neurocognitive phenotypes were identified in survivors (global impairment 3.7%, impaired attention 5.0%, memory impairment 7.2%, processing speed and executive function impairment 9.3%, no impairment 74.8%). Risk of global impairment was associated with severe chronic health condition burden (odds ratio [OR] = 20.17, 95% confidence interval [CI] = 11.41 to 35.63) including cerebrovascular disease (OR = 14.5, 95% CI = 5.47 to 38.44) and cerebrovascular accident (OR = 14.7, 95% CI = 7.50 to 26.40). Modifiable risk factors, such as quitting smoking, reduced risk for global impairment (OR = 0.21, 95% CI = 0.06 to 0.66). Low physical activity increased risk for global impairment (OR = 4.54, 95% CI = 2.86 to 7.21), attention impairment (OR = 2.01, 95% CI = 1.41 to 2.87), processing speed and executive function impairment (OR = 1.90, 95% CI = 1.46 to 2.48), and memory impairment (OR = 2.09, 95% CI = 1.54 to 2.82). Conclusions Results support the clinical utility of neurocognitive phenotyping to develop risk profiles and personalized clinical interventions, such as preventing cerebrovascular disease in anthracycline-treated survivors by preventing hypercholesterolemia, smoking, and sedentary lifestyle, to reduce the risk for global impairment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Late subsequent leukemia after childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).

Author

Ghosh, Taumoha, Hyun, Geehong, Dhaduk, Rikeenkumar, Conces, Miriam, Arnold, Michael A., Howell, Rebecca M., Henderson, Tara O., McDonald, Aaron, Robison, Leslie L., Yasui, Yutaka, Ness, Kirsten K., Armstrong, Gregory T., Neglia, Joseph P., and Turcotte, Lucie M.

Subjects
CHILDHOOD cancer, CHRONIC myeloid leukemia, MYELODYSPLASTIC syndromes, ACUTE myeloid leukemia, CANCER survivors, CHRONIC leukemia
Abstract

Background: Subsequent short‐latency leukemias are well‐described among survivors of childhood cancer. However, late (5–14.9 years from diagnosis, LL) and very late (≥15 years from diagnosis, VLL) subsequent leukemias have not been well studied. We assessed risk factors, prevalence, and outcomes for LL and VLL in the Childhood Cancer Survivor Study cohort. Methods: Subsequent leukemias, among 25,656 five‐year survivors, were self‐reported and confirmed by pathology review. Standardized incidence ratios (SIR) and cumulative incidences were calculated, and relative risks (RR) were estimated using Cox regression for exposures. Results: Seventy‐seven survivors developed subsequent leukemia, 49 survivors with LL (median time from diagnosis 7.8 years, range 5.0–14.5 years) and 28 with VLL (median time from diagnosis 25.4 years, range 15.9–42.8 years), with a cumulative incidence of 0.23% (95% CI 0.18%–0.30%) 20 years from diagnosis for all subsequent leukemias. The most common leukemia subtypes were acute myeloid leukemia, myelodysplastic syndrome, and chronic myeloid leukemia. Compared to the general population, survivors were at increased risk, for developing LL (SIR 9.3, 95% CI 7.0–12.1) and VLL (SIR 5.9, 95% CI 3.9–8.4). In multivariable relative risk analyses, cumulative epipodophyllotoxin dose >4000 mg/m2 was associated with increased risk for LL and VLL (RR 4.5, 95% CI 2.0–9.9). Conclusions: In this large series of late subsequent leukemias, survivors of childhood cancer are at increased risk, with no evidence of plateau over time. We observed most risk among survivors who received high cumulative doses of epipodophyllotoxins. Ongoing consideration for this late effect should continue beyond 10 years. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

37. Using mHealth Technology to Evaluate Daily Symptom Burden among Adult Survivors of Childhood Cancer: A Feasibility Study.

Author

Howell, Kristen E., Baedke, Jessica L., Bagherzadeh, Farideh, McDonald, Aaron, Nathan, Paul C., Ness, Kirsten K., Hudson, Melissa M., Armstrong, Gregory T., Yasui, Yutaka, and Huang, I-Chan

Subjects
PATIENT compliance, STATISTICAL models, TUMORS in children, RESEARCH funding, QUESTIONNAIRES, CANCER patients, SYMPTOM burden, SEVERITY of illness index, MULTIVARIATE analysis, DESCRIPTIVE statistics, ANXIETY, TELEMEDICINE, LONGITUDINAL method, SURVEYS, QUALITY of life, STATISTICS, SLEEP, PAIN, CONFIDENCE intervals, CANCER fatigue, REGRESSION analysis, MENTAL depression, COGNITION, DISEASE complications, SYMPTOMS
Abstract

Simple Summary: Survivors of childhood cancer are predisposed to a range of late effects of treatment, including high symptom burden. Symptom burden may vary over time. The aim of this prospective pilot study was to assess the feasibility of collecting daily symptoms from adult survivors of childhood cancer using mobile health (mHealth) technology to evaluate symptom fluctuation and associations with future health-related quality of life (HRQOL). The 41 survivors included in this study had high adherence to symptom reporting (83%) and HRQOL reporting (95%). Variability of daily symptom burden differed from person-to-person (74%), day-to-day (18%), and month-to-month (8%). Additionally, a higher symptom burden was associated with poorer HRQOL in the future. Daily assessment of symptoms using mHealth technology revealed fluctuations in symptomology and the association between symptom burden and HRQOL. This method of symptom assessment is valuable for improving our understanding of symptom dynamics and sources of variability. Background: Cancer therapies predispose survivors to a high symptom burden. This study utilized mobile health (mHealth) technology to assess the feasibility of collecting daily symptoms from adult survivors of childhood cancer to evaluate symptom fluctuation and associations with future health-related quality-of-life (HRQOL). Methods: This prospective study used an mHealth platform to distribute a 20-item cancer-related symptom survey (5 consecutive days each month) and an HRQOL survey (the day after the symptom survey) over 3 consecutive months to participants from the Childhood Cancer Survivor Study. These surveys comprised a PROMIS-29 Profile and Neuro-QOL assessed HRQOL. Daily symptom burden was calculated by summing the severity (mild, moderate, or severe) of 20 symptoms. Univariate linear mixed-effects models were used to analyze total, person-to-person, day-to-day, and month-to-month variability for the burden of 20 individual symptoms. Multivariable linear regression was used to analyze the association between daily symptom burden in the first month and HRQOL in the third month, adjusted for covariates. Results: Out of the 60 survivors invited, 41 participated in this study (68% enrollment rate); 83% reported their symptoms ≥3 times and 95% reported HRQOL in each study week across 3 months. Variability of daily symptom burden differed from person-to-person (74%), day-to-day (18%), and month-to-month (8%). Higher first-month symptom burden was associated with poorer HRQOL related to anxiety (regression coefficient: 6.56; 95% CI: 4.10–9.02), depression (6.32; 95% CI: 3.18–9.47), fatigue (7.93; 95% CI: 5.11–10.80), sleep (6.07; 95% CI: 3.43–8.70), pain (5.16; 95% CI: 2.11–8.22), and cognitive function (–6.89; 95% CI: –10.00 to –3.79) in the third month. Conclusions: Daily assessment revealed fluctuations in symptomology, and higher symptom burden was associated with poorer HRQOL in the future. Utilizing mHealth technology for daily symptom assessment improves our understanding of symptom dynamics and sources of variability. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

39. Adverse Childhood Experiences, Resilience, and Cardiovascular Disease in Adult Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study

Author

Schwartz, Lindsay F., primary, Stratton, Kayla L., additional, Leisenring, Wendy M., additional, Marron Rodriguez, Stefania, additional, Alston, Shani, additional, McDonald, Aaron, additional, Vukadinovich, Chris, additional, Rinehart, Dayton, additional, Oeffinger, Kevin C., additional, Chow, Eric J., additional, Krull, Kevin R., additional, Brinkman, Tara M., additional, Nathan, Paul C., additional, Tan, Marcia M., additional, McCrae, Julie S., additional, Burkhardt, Tiffany, additional, Ness, Kirsten K., additional, Armstrong, Gregory T., additional, and Henderson, Tara O., additional

Published
2024
Full Text
View/download PDF

40. Using an mHealth approach to collect patient-generated health data for predicting adverse health outcomes among adult survivors of childhood cancer

Author

Howell, Kristen E., primary, Shaw, Marian, additional, Santucci, Aimee K., additional, Rodgers, Kristy, additional, Ortiz Rodriguez, Izeris, additional, Taha, Danah, additional, Laclair, Sara, additional, Wolder, Carol, additional, Cooper, Christie, additional, Moon, Wonjong, additional, Vukadinovich, Christopher, additional, Erhardt, Matthew J., additional, Dean, Shannon M., additional, Armstrong, Gregory T., additional, Ness, Kirsten K., additional, Hudson, Melissa M., additional, Yasui, Yutaka, additional, and Huang, I-Chan, additional

Published
2024
Full Text
View/download PDF

42. Supplementary Methods S1 from Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma

Author

Williams, AnnaLynn M., primary, Liu, Wei, primary, Ehrhardt, Matthew J., primary, Mirzaei Salehabadi, Sedigheh, primary, Panoskaltsis-Mortari, Angela, primary, Phillips, Nicholas S., primary, Mulrooney, Daniel A., primary, Flerlage, Jamie E., primary, Yasui, Yutaka, primary, Srivastava, Deokumar, primary, Robison, Leslie L., primary, Hudson, Melissa M., primary, Ness, Kirsten K., primary, Sabin, Noah D., primary, and Krull, Kevin R., primary

Published
2024
Full Text
View/download PDF

43. Supplementary Table S2 from Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma

Author

Williams, AnnaLynn M., primary, Liu, Wei, primary, Ehrhardt, Matthew J., primary, Mirzaei Salehabadi, Sedigheh, primary, Panoskaltsis-Mortari, Angela, primary, Phillips, Nicholas S., primary, Mulrooney, Daniel A., primary, Flerlage, Jamie E., primary, Yasui, Yutaka, primary, Srivastava, Deokumar, primary, Robison, Leslie L., primary, Hudson, Melissa M., primary, Ness, Kirsten K., primary, Sabin, Noah D., primary, and Krull, Kevin R., primary

Published
2024
Full Text
View/download PDF

44. Supplementary Figure S1 from Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma

Author

Williams, AnnaLynn M., primary, Liu, Wei, primary, Ehrhardt, Matthew J., primary, Mirzaei Salehabadi, Sedigheh, primary, Panoskaltsis-Mortari, Angela, primary, Phillips, Nicholas S., primary, Mulrooney, Daniel A., primary, Flerlage, Jamie E., primary, Yasui, Yutaka, primary, Srivastava, Deokumar, primary, Robison, Leslie L., primary, Hudson, Melissa M., primary, Ness, Kirsten K., primary, Sabin, Noah D., primary, and Krull, Kevin R., primary

Published
2024
Full Text
View/download PDF

46. Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer

Author

Im, Cindy, primary, Neupane, Achal, additional, Baedke, Jessica L., additional, Lenny, Brian, additional, Delaney, Angela, additional, Dixon, Stephanie B., additional, Chow, Eric J., additional, Mostoufi-Moab, Sogol, additional, Yang, Tianzhong, additional, Richard, Melissa A., additional, Gramatges, M. Monica, additional, Lupo, Philip J., additional, Sharafeldin, Noha, additional, Bhatia, Smita, additional, Armstrong, Gregory T., additional, Hudson, Melissa M., additional, Ness, Kirsten K., additional, Robison, Leslie L., additional, Yasui, Yutaka, additional, Wilson, Carmen L., additional, and Sapkota, Yadav, additional

Published
2024
Full Text
View/download PDF

47. St. Jude Survivorship Portal: sharing and analyzing large clinical and genomic datasets from pediatric cancer survivors

Author

Matt, Gavriel Y., primary, Sioson, Edgar, additional, Shelton, Kyla, additional, Wang, Jian, additional, Lu, Congyu, additional, Zaldivar Peraza, Airen, additional, Gangwani, Karishma, additional, Paul, Robin, additional, Reilly, Colleen, additional, Acić, Aleksandar, additional, Liu, Qi, additional, Sandor, Stephanie R., additional, McLeod, Clay, additional, Patel, Jaimin, additional, Wang, Fan, additional, Im, Cindy, additional, Wang, Zhaoming, additional, Sapkota, Yadav, additional, Wilson, Carmen L., additional, Bhakta, Nickhill, additional, Ness, Kirsten K., additional, Armstrong, Gregory T., additional, Hudson, Melissa M., additional, Robison, Leslie L., additional, Zhang, Jinghui, additional, Yasui, Yutaka, additional, and Zhou, Xin, additional

Published
2024
Full Text
View/download PDF

48. Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma

Author

Williams, AnnaLynn M., primary, Liu, Wei, additional, Ehrhardt, Matthew J., additional, Mirzaei Salehabadi, Sedigheh, additional, Panoskaltsis-Mortari, Angela, additional, Phillips, Nicholas S., additional, Mulrooney, Daniel A., additional, Flerlage, Jamie E., additional, Yasui, Yutaka, additional, Srivastava, Deokumar, additional, Robison, Leslie L., additional, Hudson, Melissa M., additional, Ness, Kirsten K., additional, Sabin, Noah D., additional, and Krull, Kevin R., additional

Published
2024
Full Text
View/download PDF

49. Prediabetes and Associated Risk of Cardiovascular Events and Chronic Kidney Disease Among Adult Survivors of Childhood Cancer in the St Jude Lifetime Cohort

Author

Dixon, Stephanie B., primary, Wang, Fang, additional, Lu, Lu, additional, Wilson, Carmen L., additional, Green, Daniel M., additional, Merchant, Thomas E., additional, Srivastava, Deo Kumar, additional, Delaney, Angela, additional, Howell, Rebecca M., additional, Jefferies, John L., additional, Robison, Leslie L., additional, Ness, Kirsten K., additional, Hudson, Melissa M., additional, Chemaitilly, Wassim, additional, and Armstrong, Gregory T., additional

Published
2024
Full Text
View/download PDF

50. Severe Sepsis During Treatment for Childhood Leukemia and Sequelae Among Adult Survivors

Author

Goggin, Kathryn P., primary, Lu, Lu, additional, Lee, Danielle E., additional, Howell, Carrie R., additional, Srivastava, Deokumar, additional, Brinkman, Tara M., additional, Armstrong, Gregory T., additional, Bhakta, Nickhill, additional, Robison, Leslie L., additional, Ehrhardt, Mathew J., additional, Hudson, Melissa M., additional, Krull, Kevin R., additional, Pui, Ching-Hon, additional, Rubnitz, Jeffrey, additional, Ness, Kirsten K., additional, and Wolf, Joshua, additional

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results